Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santoni

Showing results (971-980 of 2,428) with videos related to

Pageof 243
Sort By:
Age and Ageing|June 13, 2018
Temporal trends in impairments of physical function among older adults during 2001-16 in Sweden: towards a healthier ageingGiola Santoni, Sara B Angleman, Stina Ek, et al.
Clinical Therapeutics|October 25, 2011
Economic evaluation of clodronate and zoledronate in patients diagnosed with metastatic bone disease from the perspective of public and third party payors in BrazilMarcelo Cunio Machado Fonseca, Gabriela Tannus Branco de Araújo, Helder Etto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosisM Milella, A Gismondi, P Roncaioli, et al.
Diagnostic Pathology|October 19, 2014
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
British Journal of Clinical Pharmacology|August 29, 2013
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancyRoberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, et al.
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
Hormone Research in Paediatrics|August 29, 2015
Gene Variants Associated with Transient Neonatal Diabetes Mellitus in the Very Low Birth Weight InfantSabrina Anderson de la Llana, Philippe Klee, Federico Santoni, et al.
Cancers|July 24, 2021
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker EvaluationAlessia Cimadamore, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Pageof 243

Showing results (971-980 of 2,428) with videos related to

Sort By:
Pageof 243
Age and Ageing|June 13, 2018
Temporal trends in impairments of physical function among older adults during 2001-16 in Sweden: towards a healthier ageingGiola Santoni, Sara B Angleman, Stina Ek, et al.
Clinical Therapeutics|October 25, 2011
Economic evaluation of clodronate and zoledronate in patients diagnosed with metastatic bone disease from the perspective of public and third party payors in BrazilMarcelo Cunio Machado Fonseca, Gabriela Tannus Branco de Araújo, Helder Etto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1997
CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosisM Milella, A Gismondi, P Roncaioli, et al.
Diagnostic Pathology|October 19, 2014
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
British Journal of Clinical Pharmacology|August 29, 2013
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancyRoberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, et al.
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
Hormone Research in Paediatrics|August 29, 2015
Gene Variants Associated with Transient Neonatal Diabetes Mellitus in the Very Low Birth Weight InfantSabrina Anderson de la Llana, Philippe Klee, Federico Santoni, et al.
Cancers|July 24, 2021
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker EvaluationAlessia Cimadamore, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 19, 2021
Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysisAlessandro Rizzo, Sara Merler, Giulia Sorgentoni, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Pageof 243